Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (2.848)

121

Hereditary breast and ovarian cancer : from genes to molecular targeted therapies

enthalten in: Critical reviews in clinical laboratory sciences | 2023

von Ponti, G. | De Angelis, C. | Ponti, R. | +5

122

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Pujade-Lauraine, E. | Selle, F. | Scambia, G. | +21

CommentOn: Ann Oncol. 2023 Dec;34(12):1074-1076. - PMID 38072509

123

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

124

A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)

enthalten in: Journal of neuro-oncology | 2023

von Kleinberg, L. | Ye, X. | Supko, J. | +7

UpdateOf: Res Sq. 2023 Oct 24;:. - PMID 37961385

125

Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects

enthalten in: Investigational new drugs | 2023

von Kim, H. | Yang, E. | Lee, S. | +7

126

Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Magadeeva, S. | Qian, X. | Korff, N. | +8

127

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors : A Phase I Trial

enthalten in: The oncologist | 2023

von Cao, J. | Guo, H. | Ji, D. | +8

128

Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer

enthalten in: Future oncology (London, England) | 2023

von Akbıyık, I. | Ürün, Y.

129

Efficacy and safety of PARP inhibitor in non-small cell lung cancer : a systematic review with meta-analysis

enthalten in: Chinese clinical oncology | 2023

von Olivares-Hernández, A. | Roldán-Ruiz, J. | Miramontes-González, J. | +7

130

PARP Inhibitors in Colorectal Malignancies : A 2023 Update

enthalten in: Reviews on recent clinical trials | 2023

von Skouteris, N. | Papageorgiou, G.